Tétu, P.; Sirven-Villaros, L.; Cuzzubbo, S.; Ursu, R.; Baroudjian, B.; Delyon, J.; Nataf, F.; De Margerie-Mellon, C.; Allayous, C.; Lefevre, W.;
et al. Impact of New Systemic Treatment and Radiotherapy in Melanoma Patients with Leptomeningeal Metastases. Cancers 2020, 12, 2635.
https://doi.org/10.3390/cancers12092635
AMA Style
Tétu P, Sirven-Villaros L, Cuzzubbo S, Ursu R, Baroudjian B, Delyon J, Nataf F, De Margerie-Mellon C, Allayous C, Lefevre W,
et al. Impact of New Systemic Treatment and Radiotherapy in Melanoma Patients with Leptomeningeal Metastases. Cancers. 2020; 12(9):2635.
https://doi.org/10.3390/cancers12092635
Chicago/Turabian Style
Tétu, Pauline, Lila Sirven-Villaros, Stefania Cuzzubbo, Renata Ursu, Barouyr Baroudjian, Julie Delyon, François Nataf, Constance De Margerie-Mellon, Clara Allayous, Wendy Lefevre,
and et al. 2020. "Impact of New Systemic Treatment and Radiotherapy in Melanoma Patients with Leptomeningeal Metastases" Cancers 12, no. 9: 2635.
https://doi.org/10.3390/cancers12092635
APA Style
Tétu, P., Sirven-Villaros, L., Cuzzubbo, S., Ursu, R., Baroudjian, B., Delyon, J., Nataf, F., De Margerie-Mellon, C., Allayous, C., Lefevre, W., Carpentier, A. F., & Lebbé, C.
(2020). Impact of New Systemic Treatment and Radiotherapy in Melanoma Patients with Leptomeningeal Metastases. Cancers, 12(9), 2635.
https://doi.org/10.3390/cancers12092635